Elaine Jones, vice-president at pharmaceutical company Pfizer’s corporate venture capital unit, has shared highlights of her career with GCV ahead of her departure in April.

After two decades in venture capital and business development applying pharmaceutical research, Elaine Jones, executive director of pharmaceutical firm Pfizer’s corporate venturing subsidiary, Pfizer Ventures, will retire at the end of next month. Jones told Global Corporate Venturing: “Taking my science background and using it as a springboard into the business end of the pharmaceutical…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.